Published in Pharma Law Weekly, May 24th, 2005
Acacia Research Corporation comprises two operating groups, the Acacia Technologies group and the CombiMatrix group.
"Acacia Technologies group revenues for the first quarter of 2005 were $1,863,000, consisting of licensing revenues from our Digital Media Transmission (DMT), credit card fraud protection, digital video production, and interactive television technologies. We also received payments of $527,000 from licensees that we recorded as deferred revenues," commented Paul Ryan, Acacia Research Corporation chairman & CEO.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly